← Leaderboards
Todd Wallach
Oncosting Llc
$3,261,288
Attributed
$3,261,288
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,261,288 · 2
By mechanism
R44$3,261,288 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Overexpression”
- David G Brooks · Boston Immune Technologies And Therapeutics, Inc.$3,974,764
- Xu Chen · University Of California, San Francisco$3,581,285
- Osama Al Dalahmah · Columbia University Health Sciences$3,409,585
- Rudy Paladini · Halo Biosciences, Inc.$2,993,376
- Fouad T Chebib · Mayo Clinic Jacksonville$2,967,657
- Reeder McNeil Robinson · Leukogene Therapeutics, Inc.$2,940,211
Research focus
OverexpressionPathway InteractionsIn VitroIntravesicalMalignant Neoplasm Of Urinary BladderNon-Muscle Invasive Bladder CancerBcg LiveCovid-19DoseImmunityMacrophageAntibiotic ResistanceNext GenerationMyeloid CellsAgonistBacterial VaccinesClinical TrialsCessation Of LifeAttenuated VaccinesDna CassetteFermentationGrowthLiquid SubstancePhase 3 Study
Grant awards (4)
BCG overexpressing a small molecule STING agonist as a vaccine for TB$991,112
R44 · FY2025 · AI · contact PI
BCG overexpressing a small molecule STING agonist as a vaccine for TB$270,176
R44 · FY2024 · AI · contact PI
STING agonist-expressing BCG for bladder cancer$1,092,982
R44 · FY2023 · CA · contact PI
STING agonist-expressing BCG for bladder cancer$907,018
R44 · FY2022 · CA · contact PI